ArticleBMC oral health2026
Pemphigus vulgaris-a blistering clinical enigma: case report.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUpper aerodigestive tract involvement in pemphigus requires early multidisciplinary evaluation because there can be involvement in the oral cavity, pharynx, larynx and glottis and thus to upper airway as well. Pemphigus vulgaris (PV) is an autoimmune blistering disorder characterized by painful mucocutaneous vesicles and bullae that rupture to form severe erosions. The disease results in intraepithelial blister formation due to immunoglobulin G autoantibodies targeting desmoglein-3(DSG3), and sometimes desmoglein 1(DSG1). Oral lesions are the most common manifestation and serve as the initial sign in 80-90% of cases. Early diagnosis and management of oral involvement are essential to prevent skin lesions and improve the likelihood of achieving early remission. Corticosteroids remain the cornerstone of therapy. CASE PRESENTATION: A 35-year-old South Asian male of Indian origin, belonging to the Dravidian ethnic group, presented with a one-month history of multiple ulcers in the oral cavity marked by intermittent exacerbations and remissions. Extra-oral examination revealed multiple blisters in chest and back of the body. Intra-oral examination revealed multiple oral ulcers and an exfoliative cytology revealed scattered exfoliated epithelial cells and clumps of rounded acantholytic cells resembling Tzanck cells. Oral incisional biopsy was done for histopathological and immunological investigations and a definitive diagnosis of Pemphigus Vulgaris was made .
conclusionThis case highlights the importance of thorough clinical evaluation, careful histopathological and immunofluorescence studies to distinguish PV from a broad range of mucocutaneous blistering disorders. Despite limitations in therapeutic availability, appropriate use of systemic corticosteroids, supportive care, and consideration of steroid-sparing agents are critical components of treatment. Multidisciplinary collaboration is essential, especially in cases with upper aerodigestive tract involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.